TG Therapeutics | TGTX - Gewinn Vor Steuern





Gewinn Vor Steuern Veränderung Datum
AbbVie USD 4.38B 1.92B 2025-09
Alaunos Therapeutics USD -7.84M 633K 2023-12
Amgen USD 3.92B 2.35B 2025-09
Ardelyx USD -400K 467K 2025-12
Arrowhead Research USD 28.27M 7.85M 2025-12
Bayer EUR -1.16B 735M 2025-09
Biogen USD 557.3M 186.7M 2025-09
Corcept Therapeutics USD 15.24M 16.45M 2025-09
Curis USD -13.99M 7.38M 2025-06
Gilead Sciences USD 3.64B 1.21B 2025-09
Infinity Pharmaceuticals USD -9.96M 1.09M 2023-06
J&J USD 4.97B 2.53B 2025-12
Karyopharm Therapeutics USD -30.89M 1.16M 2024-12
Novartis USD 4.64B 445M 2025-12
Novavax USD 17.9M 220.94M 2025-12
PTC Therapeutics USD -139.08M 116.01M 2025-12
Puma Biotechnology USD 20.61M 24.76M 2024-09
Regeneron Pharmaceuticals USD 1.76B 244.6M 2025-09
Roche Holding CHF 4.79B 3.01B 2025-06
TG Therapeutics USD 45.09M 19.18M 2025-12
Verastem USD -33.86M 6.49M 2024-03
Vertex Pharmaceuticals USD 1.3B 15.8M 2025-09